Donepezil NOBEL lingual 5 mg

Donepezil NOBEL lingual 5 mg is a medicine authorised by Swissmedic under authorisation number 68060. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 October 2021 and the authorisation is valid without a time limit. ATC code N06DA02 places the medicine in the group Psychoanaleptics.

  • Dispensing category B
  • Authorisation number 68060
  • ATC N06DA02
  • Synthetic medicines
Authorisation data
Authorisation number68060
NameDonepezil NOBEL lingual 5 mg
Full nameDonepezil NOBEL lingual 5 mg, Schmelztabletten
Authorisation holderNOBEL Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN06DA02
First authorisation08 October 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Donepezil NOBEL lingual 5 mg, SchmelztablettenB08 October 2021
2Donepezil NOBEL lingual 10 mg, SchmelztablettenB08 October 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Tablette(n)N06DA0201.99.0.B
298Tablette(n)N06DA0201.99.0.B
328Tablette(n)N06DA0201.99.0.B
498Tablette(n)N06DA0201.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Donepezil NOBEL lingual 5 mg authorised in Switzerland?

Yes. Donepezil NOBEL lingual 5 mg is authorised by Swissmedic under authorisation number 68060, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Donepezil NOBEL lingual 5 mg have?

Donepezil NOBEL lingual 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Donepezil NOBEL lingual 5 mg?

The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com